HOME >> BIOLOGY >> NEWS
Oral contraceptives increase C-reactive protein, an infIammatory biomarker

nd 22 after menses. Plasma samples were later thawed and assayed for CRP by use of a high-sensitivity assay.

Results

There were no significant differences in baseline demographic characteristics between oral contraceptive users and nonusers. Plasma CRP levels were two times higher among OC users than among non-users independent of diet assignment, diet treatment order, and phase of the menstrual cycle. In a multivariate model, OC use predicted 32 percent of the variance in CRP levels. As all CRP levels were within a previously established normal range, further study is indicated to establish the clinical significance of the observed elevated CRP levels in OC users.

Conclusions

The results from this research and past studies suggest that estrogenic hormones significantly affect pro-inflammatory pathways. Whether these changes have clinical significance remains to be determined. The present data also showed that CRP levels are higher in the luteal, or post-ovulatory phase, versus the follicular phase. This association was more pronounced in OC users than non-users.

This cross-sectional survey demonstrates that CRP levels are significantly increased among OC users versus non-users. The possibility that these results are due to chance or confounding variables cannot be excluded entirely, and the results need to be confirmed by larger independent studies. The researchers suggest that the impact of OC use on CRP and inflammatory parameters should be investigated in prospective trials.


'"/>

Contact: Donna J. Krupa
djkrupa1@aol.com
American Physiological Society
9-Apr-2003


Page: 1 2 3

Related biology news :

1. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
2. Study suggests newer oral contraceptives may be less harmful for women smokers
3. USC study links historical increases in life span to lower childhood exposure to infection
4. Study narrows search for genes placing men at increased risk for prostate cancer
5. Rare mutations can significantly increase risk factor for heart disease
6. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
7. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
8. Study links high carbohydrate diet to increased breast cancer risk
9. Carnivore species are predicted to be at increased extinction risk from human population growth
10. DFG announces three percent budget increase
11. Animal research suggests plant estrogens in soy do not increase breast cancer risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/13/2018)... CITY, N.J. (PRWEB) , ... December 12, 2018 ... ... the research and advancement of regenerative cellular therapy, has announced the launch of ... new technique to a gold standard approach of aspirating a patients autologous bone ...
(Date:12/13/2018)... FRANCISCO (PRWEB) , ... December 13, 2018 , ... ... sciences, just released a must-see documentary entitled “What Researchers Need to Know ... Reproducibility Issues in Life Science Research series. The goal of this film is ...
(Date:12/6/2018)... ... December 06, 2018 , ... ... instruments, consumables and laboratory contract services, throughout his career. During his recent five-year ... US Sales team and established the commercial laboratory operations in Brunswick, Maine. Through ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... 2019 , ... The American Society of Gene and Cell Therapy’s ... committee made up of industry leaders identified by the ASGCT board of directors. In ... created to support ASGCT members designing transformative pilot studies in gene and cell therapy ...
(Date:1/4/2019)... (PRWEB) , ... January 02, 2019 , ... ... technology to detect precancer and cancer cells in blood, has been named as ... , a global biotech company developing cell therapies for cancer treatment, will use ...
(Date:12/19/2018)... FREDERICK, Md. (PRWEB) , ... December 19, 2018 ... ... solutions for Life Science, announces the validated release of Limfinity® version 7.1. The ... another important technical offering from RURO as 2018 comes to an end. , ...
(Date:12/14/2018)... EDMONTON, Alberta (PRWEB) , ... December 14, 2018 ... ... the Eye Machine Canada Inc., have been given the green light to immediately ... Age-Related Macular Degeneration (AMD). , The medical devices bureau of Health Canada has ...
Breaking Biology Technology:
Cached News: